| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
59,420,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Generation Bio is a genetic medicines company providing durable, redosable treatments for potentially various of patients living with rare and prevalent diseases. Co.'s non-viral genetic medicine platform incorporates its DNA construct called closed-ended DNA; its cell-targeted lipid nanoparticle delivery system; and its capsid-free manufacturing process that uses its proprietary cell-free rapid enzymatic synthesis, to produce ceDNA. Using Co.'s platform, it is developing genetic medicines to provide targeted delivery of genetic payloads that include large and multiple genes to a range of cell types across a range of diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
551,455 |
551,455 |
642,217 |
| Total Buy Value |
$0 |
$778,895 |
$778,895 |
$1,265,385 |
| Total People Bought |
0 |
4 |
4 |
4 |
| Total Buy Transactions |
0 |
7 |
7 |
12 |
| Total Shares Sold |
0 |
4,890 |
11,122 |
27,899 |
| Total Sell Value |
$0 |
$7,922 |
$39,768 |
$125,583 |
| Total People Sold |
0 |
2 |
2 |
2 |
| Total Sell Transactions |
0 |
2 |
4 |
10 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kerr Douglas |
CHIEF MEDICAL OFFICER |
• – – |
2024-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,131 |
384,403 |
|
- |
|
| Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
• – – |
2024-01-15 |
4 |
D |
$1.91 |
$9,353 |
D/D |
(4,897) |
243,773 |
|
- |
|
| Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
• – – |
2024-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,131 |
246,093 |
|
- |
|
| Mcdonough Geoff |
PRESIDENT AND CEO |
• • – |
2024-01-15 |
4 |
D |
$1.91 |
$29,473 |
D/D |
(15,431) |
1,319,732 |
|
- |
|
| Mcdonough Geoff |
PRESIDENT AND CEO |
• • – |
2024-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
44,531 |
1,327,042 |
|
- |
|
| Paone Antoinette |
CHIEF OPERATING OFFICER |
• – – |
2024-01-02 |
4 |
AS |
$1.62 |
$3,961 |
D/D |
(2,445) |
5,828 |
|
- |
|
| Samayoa Phillip |
CHIEF STRATEGY OFFICER |
• – – |
2024-01-02 |
4 |
AS |
$1.62 |
$3,961 |
D/D |
(2,445) |
107,256 |
|
- |
|
| Appelhans Dannielle |
|
– • – |
2023-12-08 |
4 |
B |
$1.79 |
$13,180 |
I/I |
7,363 |
7,363 |
0.01 |
- |
|
| Appelhans Dannielle |
|
– • – |
2023-12-08 |
4 |
B |
$1.82 |
$1,159 |
D/D |
637 |
12,637 |
0.01 |
- |
|
| Appelhans Dannielle |
|
– • – |
2023-12-04 |
4 |
B |
$1.50 |
$18,000 |
D/D |
12,000 |
12,000 |
0.01 |
- |
|
| Rowland Charles A Jr |
|
– • – |
2023-12-04 |
4 |
B |
$1.50 |
$225,000 |
D/D |
150,000 |
534,757 |
0.01 |
- |
|
| Nicholson Donald William |
|
– • – |
2023-12-01 |
4 |
B |
$1.44 |
$144,000 |
D/D |
100,000 |
213,576 |
0.01 |
- |
|
| Quinn Anthony |
|
– • – |
2023-12-01 |
4 |
B |
$1.41 |
$124,778 |
D/D |
88,495 |
88,495 |
0.01 |
- |
|
| Rowland Charles A Jr |
|
– • – |
2023-12-01 |
4 |
B |
$1.31 |
$252,778 |
D/D |
192,960 |
384,757 |
0.01 |
- |
|
| Norkunas Matthew |
CHIEF FINANCIAL OFFICER |
• – – |
2023-10-15 |
4 |
D |
$3.24 |
$8,667 |
D/D |
(2,675) |
39,932 |
|
- |
|
| Norkunas Matthew |
CHIEF FINANCIAL OFFICER |
• – – |
2023-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,111 |
40,424 |
|
- |
|
| Kerr Douglas |
CHIEF MEDICAL OFFICER |
• – – |
2023-10-15 |
4 |
D |
$3.24 |
$7,073 |
D/D |
(2,183) |
370,404 |
|
- |
|
| Kerr Douglas |
CHIEF MEDICAL OFFICER |
• – – |
2023-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,437 |
372,587 |
|
- |
|
| Samayoa Phillip |
CHIEF STRATEGY OFFICER |
• – – |
2023-10-15 |
4 |
D |
$3.24 |
$3,924 |
D/D |
(1,211) |
107,256 |
|
- |
|
| Samayoa Phillip |
CHIEF STRATEGY OFFICER |
• – – |
2023-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,125 |
108,467 |
|
- |
|
| Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
• – – |
2023-10-15 |
4 |
D |
$3.24 |
$7,073 |
D/D |
(2,183) |
36,385 |
|
- |
|
| Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
• – – |
2023-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,437 |
38,568 |
|
- |
|
| Paone Antoinette |
CHIEF OPERATING OFFICER |
• – – |
2023-10-15 |
4 |
D |
$3.24 |
$3,924 |
D/D |
(1,211) |
5,828 |
|
- |
|
| Paone Antoinette |
CHIEF OPERATING OFFICER |
• – – |
2023-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,125 |
7,039 |
|
- |
|
| Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
• – – |
2023-10-15 |
4 |
D |
$3.24 |
$7,073 |
D/D |
(2,183) |
234,539 |
|
- |
|
293 Records found
|
|
Page 2 of 12 |
|
|
